tiprankstipranks
Urogen Pharma (URGN)
NASDAQ:URGN
US Market
URGN
Urogen Pharma
RESEARCH TOOLSreports

Urogen Pharma (URGN) Income Statement

654 Followers

Urogen Pharma Income Statement

Last quarter (Q4 2025), Urogen Pharma's total revenue was $37.84M, an increase of 54.03% from the same quarter last year. In Q4, Urogen Pharma's net income was $-26.36M. See Urogen Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 109.79M$ 90.40M$ 82.71M$ 64.36M$ 48.04M
Gross Profit
$ 97.34M$ 81.52M$ 73.35M$ 56.70M$ 42.88M
Operating Expenses
$ 222.20M$ 178.30M$ 138.89M$ 135.74M$ 135.18M
Depreciation and Amortization
$ 2.41M$ 329.00K$ 1.71M$ 1.82M$ 831.00K
EBITDA
$ -135.66M$ -95.35M$ -60.35M$ -76.21M$ -91.46M
Operating Income
$ -124.86M$ -96.78M$ -65.54M$ -79.04M$ -92.29M
Other Income/Expenses
$ -28.55M$ -27.26M$ -32.79M$ -28.99M$ -17.08M
Pretax Income
$ -153.42M$ -124.04M$ -98.32M$ -108.03M$ -109.37M
Net Income
$ -153.49M$ -126.87M$ -102.24M$ -109.78M$ -110.82M
Per Share Metrics
Basic EPS
$ -3.19$ -2.96$ -3.55$ -4.79$ -4.96
Diluted EPS
$ -3.19$ -2.96$ -3.55$ -4.79$ -4.96
Weighted Average Shares Outstanding
 48.12M 42.88M 28.83M 22.81M 22.35M
Weighted Average Shares Outstanding (Diluted)
 48.12M 42.88M 28.83M 22.81M 22.35M
Currency in USD

Urogen Pharma Earnings and Revenue History